https://le-biohacker.fr/en/actualites/parkinson-irm-locus-coeruleus-differences-sans-validation-diagnostiqueLe Biohackeren2026-10-24T14:25:52.601ZParkinson’s: MRI differences in the locus coeruleus, without individual diagnostic validationhttps://le-biohacker.fr/en/actualites/alcool-reponse-cerebrale-baclofene-forts-consommateursLe Biohackeren2026-10-24T13:25:33.219ZAlcohol: brain response to baclofen differs in heavy drinkershttps://le-biohacker.fr/en/actualites/surpoids-antipsychotiques-glp-1-efficacite-securite-psychiatriqueLe Biohackeren2026-10-24T12:25:32.108ZExcess weight during antipsychotic treatment: GLP-1 agonists appear effective, but psychiatric safety remains uncertainhttps://le-biohacker.fr/en/actualites/arret-tabac-conseiller-chatbot-piste-a-confirmerLe Biohackeren2026-10-24T11:25:55.578ZSmoking cessation: adding a counselor to chatbot support still needs confirmationhttps://le-biohacker.fr/en/actualites/instabilite-chronique-cheville-essai-biofeedback-sonore-marcheLe Biohackeren2026-10-24T10:25:23.412ZChronic ankle instability: a trial will evaluate auditory biofeedback during walkinghttps://le-biohacker.fr/en/actualites/cancers-digestifs-cachexie-complications-chirurgieLe Biohackeren2026-10-24T09:26:01.792ZGastrointestinal cancers: cachexia associated with more complications after surgery, with very uncertain evidencehttps://le-biohacker.fr/en/actualites/preeclampsie-indice-triglycerides-glucose-limites-depistageLe Biohackeren2026-10-24T08:25:37.028ZPreeclampsia: the triglyceride-glucose index remains inadequate for stand-alone screeninghttps://le-biohacker.fr/en/actualites/huntington-antidopaminergiques-declin-associationLe Biohackeren2026-10-24T07:25:20.902ZHuntington’s: antidopaminergic drugs associated with greater decline, without proven causalityhttps://le-biohacker.fr/en/actualites/alzheimer-score-erica-stades-cognitifs-preuves-limiteesLe Biohackeren2026-10-24T06:25:31.322ZAlzheimer’s: the ERICA score distinguishes certain cognitive stages, based on evidence that remains limitedhttps://le-biohacker.fr/en/actualites/nac-neuropathie-oxaliplatine-essai-benefice-court-termeLe Biohackeren2026-10-24T05:25:31.001ZNAC and oxaliplatin-related neuropathy: a small trial reports a short-term benefithttps://le-biohacker.fr/en/actualites/mash-qualite-de-vie-marqueurs-irmLe Biohackeren2026-10-24T04:25:57.355ZMASH: poorer quality of life in patients with elevated MRI markershttps://le-biohacker.fr/en/actualites/troubles-cognitifs-assistant-vocal-essai-pilote-domicileLe Biohackeren2026-10-24T03:25:31.872ZCognitive impairment: a voice assistant tested at home, with no overall benefit demonstratedhttps://le-biohacker.fr/en/actualites/allopurinol-infarctus-goutte-association-fragileLe Biohackeren2026-10-24T02:25:29.891ZAllopurinol and heart attacks in gout: a favorable but fragile associationhttps://le-biohacker.fr/en/actualites/diabete-gestationnel-telemedecine-preuves-fragilesLe Biohackeren2026-10-24T01:26:06.650ZGestational diabetes: telemedicine could help, but the evidence remains weakhttps://le-biohacker.fr/en/actualites/diabete-type-2-cible-hba1c-mortalite-analyse-j-doit3Le Biohackeren2026-10-24T00:25:30.596ZType 2 diabetes: an analysis explores an HbA1c target below 6.5%, without establishing an optimal thresholdhttps://le-biohacker.fr/en/actualites/topiramate-acidose-revue-cas-mecanismeLe Biohackeren2026-10-23T14:25:43.833ZTopiramate and acidosis: a case review questions the usual explanationhttps://le-biohacker.fr/en/actualites/syndrome-nephrotique-aigu-exercice-petit-essaiLe Biohackeren2026-10-23T13:25:34.492ZAcute nephrotic syndrome: a small trial suggests exercise may help, but findings are inconclusivehttps://le-biohacker.fr/en/actualites/demence-soutien-aidants-realisable-benefice-non-demontreLe Biohackeren2026-10-23T12:25:30.895ZDementia: caregiver support is feasible, but no benefit demonstrated for caregiver burdenhttps://le-biohacker.fr/en/actualites/cancer-poumon-capacite-physique-associee-survieLe Biohackeren2026-10-23T11:25:42.549ZNon-small cell lung cancer: physical capacity is associated with survivalhttps://le-biohacker.fr/en/actualites/obesite-infantile-protocole-suzhou-intervention-combineeLe Biohackeren2026-10-23T10:25:34.015ZChildhood obesity: a protocol in Suzhou to evaluate a combined interventionhttps://le-biohacker.fr/en/actualites/alcool-alimentation-riche-graisses-lesions-foie-rongeursLe Biohackeren2026-10-23T09:25:29.554ZAlcohol and high-fat diets: worse liver damage in rodentshttps://le-biohacker.fr/en/actualites/memoire-travail-dopamine-selection-informationsLe Biohackeren2026-10-23T08:25:39.526ZWorking memory: blocking dopamine receptors changes information selectionhttps://le-biohacker.fr/en/actualites/exercice-avant-chirurgie-cancer-essai-piloteLe Biohackeren2026-10-23T07:25:30.756ZExercise before cancer surgery: a pilot trial encouraging for participation, not efficacyhttps://le-biohacker.fr/en/actualites/depression-perinatale-memoire-plaintes-tests-peu-concluantsLe Biohackeren2026-10-23T06:25:36.121ZPerinatal depression and memory: more frequent complaints, but largely inconclusive testshttps://le-biohacker.fr/en/actualites/vaccins-covid-pneumocoque-grippe-essai-coadministrationLe Biohackeren2026-10-23T02:25:31.165ZCovid-19, pneumococcal and flu vaccines: a Chinese trial evaluates coadministrationhttps://le-biohacker.fr/en/actualites/depression-post-partum-ocytocine-reconnaissance-tristesse-nourrissonsLe Biohackeren2026-10-23T01:25:24.266ZPostpartum depression: oxytocin alters recognition of infant sadness, with no demonstrated clinical benefithttps://le-biohacker.fr/en/actualites/depression-semaglutide-choix-tache-experimentaleLe Biohackeren2026-10-23T00:25:34.954ZDepression: semaglutide changes some choices in an experimental task